What oral antibiotic is recommended for uncomplicated listeriosis without central nervous system involvement?

Oral Antibiotic for Uncomplicated Listeriosis

For uncomplicated listeriosis without CNS involvement, trimethoprim-sulfamethoxazole (TMP-SMX) is the recommended oral antibiotic option, dosed at 10-20 mg/kg/day based on the trimethoprim component, divided into 4 doses daily for 14 days. 1, 2

First-Line Considerations

While ampicillin or amoxicillin remains the gold standard for listeriosis treatment, these are typically administered intravenously for serious infections. 3, 1 However, for patients who:

• Have uncomplicated bacteremia without CNS involvement
• Are clinically stable and improving on IV therapy
• Can tolerate oral medications
• Have no immunocompromising conditions requiring prolonged IV therapy

TMP-SMX represents the best oral alternative and is specifically recommended by the Infectious Diseases Society of America and Centers for Disease Control and Prevention as the preferred alternative for penicillin-allergic patients. 1, 2

Dosing Specifics

• TMP-SMX: 10-20 mg/kg/day (based on trimethoprim component) divided into 4 doses 2
• Duration: 14 days for uncomplicated bacteremia without CNS involvement 2
• If CNS involvement is present, treatment duration extends to 21 days and IV therapy is mandatory 3, 2

Critical Pitfalls to Avoid

Never use cephalosporins for listeriosis. Listeria monocytogenes is naturally resistant to all cephalosporins, including third-generation agents like ceftriaxone and cefotaxime. 3, 1, 2 This is a common and potentially fatal error in empiric therapy.

Fluoroquinolones should be avoided despite in vitro susceptibility data, as they are not reliably active against L. monocytogenes in clinical practice. 2, 4

Alternative Oral Options

While less well-studied, the following have demonstrated in vitro activity:

• Erythromycin: May be considered in pregnancy when penicillins are contraindicated, though data are limited 5
• Rifampin: Shows excellent in vitro activity and may be considered in combination therapy, though clinical validation is lacking 6, 7

However, TMP-SMX remains the only oral agent with substantial clinical evidence supporting its use as monotherapy for listeriosis. 1, 2, 4

When Oral Therapy Is Appropriate

Oral therapy should only be considered when:

• Blood cultures have cleared on IV therapy 5
• Patient is afebrile and clinically stable 8
• No evidence of CNS involvement (normal neurological exam, no meningeal signs) 3, 2
• Patient is not severely immunocompromised 1
• Adequate oral absorption is ensured 5

Monitoring During Oral Therapy

• Clinical reassessment every 2-3 days initially 8
• Repeat blood cultures if fever recurs 8
• Complete the full 14-day course even if symptoms resolve earlier 2

The mortality rate for listeriosis remains 22-50% even with appropriate treatment, emphasizing the importance of correct antibiotic selection and adequate treatment duration. 8, 9